Advanced Medical Solutions Group plc (AIM:AMS)
London · Delayed Price · Currency is GBP · Price in GBX 281.50
-1.00 (-0.35%)
Oct 1, 2026, 5:15 PM GMT
AIM:AMS Market Cap
AIM:AMS has a market cap or net worth of 610.29 million as of October 1, 2026. Its market cap has increased by 26.13% in one year.
Market Cap
610.29M
Enterprise Value
683.30M
Revenue
233.63M
Ranking
n/a
PE Ratio
170.11
Stock Price
281.50
ChartMarket Cap Chart
Since April 11, 2000, AIM:AMS's market cap has increased from 11.11M to 610.29M, an increase of 5,394.59%. That is a compound annual growth rate of 16.33%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 1, 2026 | 610.29M | 29.79% |
| Dec 31, 2025 | 470.21M | 11.01% |
| Dec 31, 2024 | 423.58M | -6.07% |
| Dec 29, 2023 | 450.96M | -19.69% |
| Dec 30, 2022 | 561.49M | -23.12% |
| Dec 31, 2021 | 730.32M | 39.54% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 190.47B |
| GSK plc | 73.41B |
| Haleon | 29.74B |
| Smith & Nephew | 8.49B |
| Spire Healthcare Group | 987.47M |
| CVS Group | 825.75M |
| Oxford Biomedica | 631.82M |
| Craneware | 369.26M |